Early Drug-Discovery Efforts towards the Identification of EP300/CBP Histone Acetyltransferase (HAT) Inhibitors.
Huhn, A.J., Gardberg, A.S., Poy, F., Brucelle, F., Vivat, V., Cantone, N., Patel, G., Patel, C., Cummings, R., Sims, R., Levell, J., Audia, J.E., Bommi-Reddy, A., Wilson, J.E.(2020) ChemMedChem 15: 955-960
- PubMed: 32181984 
- DOI: 10.1002/cmdc.202000007
- Primary Citation of Related Structures:  
6V8B, 6V8K, 6V8N, 6V90 - PubMed Abstract: 
EP300 and CBP (KAT3A/3B) are two highly homologous, multidomain, epigenetic coregulators that play central roles in transcription through the acetylation of lysine residues on histones and other proteins. Both enzymes have been implicated in human diseases, especially cancer ...